ECSP993015A - Formulaciones de ziprasidona - Google Patents

Formulaciones de ziprasidona

Info

Publication number
ECSP993015A
ECSP993015A ECSP993015A ECSP993015A EC SP993015 A ECSP993015 A EC SP993015A EC SP993015 A ECSP993015 A EC SP993015A EC SP993015 A ECSP993015 A EC SP993015A
Authority
EC
Ecuador
Prior art keywords
crystalline ziprasidone
ziprasidone
formulations
ziprasidone formulations
schizophrenia
Prior art date
Application number
Other languages
English (en)
Inventor
Frank Robert Busch
Bijan Rasadi
Angela Carol Gatlin Hausberger
Daniel Ray Arenson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993015 priority Critical patent/ECSP993015A/es
Publication of ECSP993015A publication Critical patent/ECSP993015A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones que comprenden partículas de base libre de ziprasidona cristalina o de hidrocloruro de ziprasidona cristalino, que tienen un tamaño medio de particulas inferior a 85 um y un vehículo farmacéuticamente aceptable son sustancialmente bioequivalente y se pueden usar para tratar psicósis, como esquizofrenia.
ECSP993015 1999-06-15 1999-06-15 Formulaciones de ziprasidona ECSP993015A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993015 ECSP993015A (es) 1999-06-15 1999-06-15 Formulaciones de ziprasidona

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993015 ECSP993015A (es) 1999-06-15 1999-06-15 Formulaciones de ziprasidona

Publications (1)

Publication Number Publication Date
ECSP993015A true ECSP993015A (es) 1999-10-06

Family

ID=42044004

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993015 ECSP993015A (es) 1999-06-15 1999-06-15 Formulaciones de ziprasidona

Country Status (1)

Country Link
EC (1) ECSP993015A (es)

Similar Documents

Publication Publication Date Title
CO5070579A1 (es) Formulaciones de ziprasidona
MY129356A (en) Electrospun pharmaceutical compositions
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
EA200100519A1 (ru) Композиции на основе тонкоизмельченного эплеренона
IL140710A0 (en) Pulmonary delivery of active agents
IL153297A0 (en) Compounds and compositions for delivering active agents
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
PT1318788E (pt) Composições de dose sólida em nanopartículas
PL349173A1 (en) Cosmetic compositions of high holding stability
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
DE60324544D1 (de) Muskarin antagonisten
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
PL356100A1 (en) Lipoxin a4
SE0102843L (sv) Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod
MY133503A (en) Selective iglur5 receptor antagonists for the treatment of migrane
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
SE0003476D0 (sv) Compounds
ATE302004T1 (de) Stabile orale zusammensetzung enthaltend benzimidazol derivate
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
BR0012751A (pt) Benzofuranos serotonérgicos
ECSP993015A (es) Formulaciones de ziprasidona
ES2159260A1 (es) Nueva composicion de metanosulfonato de paroxetina
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.